3型IP3受体:它的结构,功能和相关疾病影响
1Institute of Clinical Medicine, The Second Affiliated Hospital of Hainan Medical University, Haikou, China.
Channels (Austin, Tex.)
|October 11, 2023
概括
3型伊诺西1,4,5-三酸盐受体 (IP3R3) 调节细胞内 (Ca2+) 从内细胞网膜释放. 这篇评论详细介绍了IP3R3的细节.
科学领域:
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 细胞命运的决定依赖于信号分子和转录因子的精确调节,特别是细胞内 (Ca2+) 恒温.
- 3型伊诺西1,4,5-三酸盐受体 (IP3R3) 是一个四基通道,在细胞外刺激时调解从内分泌网膜 (ER) 释放Ca2+的过程.
- IP3R3关受连接体和相互作用蛋白质的影响,这对其生物功能和疾病机制至关重要.
研究的目的:
- 审查IP3R3.3研究中的最新进展.
- 提供关于IP3R3结构,生物功能和致病机制的文献的全面概述.
主要方法:
- 对IP3R3.3现有研究的文献综述.
- 对研究的分析,重点是IP3R3结构,配体结合,蛋白相互作用和疾病相关性.
主要成果:
- 广泛的研究已经阐明了IP3R3.3的基本结构.
- 通过配体和相互作用的蛋白质对IP3R3调节的理解得到了深入.
- 对IP3R3的生物学作用和参与疾病的新见解已经出现.
结论:
- IP3R3是细胞内Ca2+动态的关键调节者,影响细胞命运.
- 对IP3R3结构功能关系及其致病作用的持续研究至关重要.
- 本综述综合了当前的知识,突出了IP3R3.3的未来研究方向.
更多相关视频
07:26Single-molecule Super-resolution Imaging of Phosphatidylinositol 4,5-bisphosphate in the Plasma Membrane with Novel Fluorescent Probes
Published on: October 15, 2016
9.6K
11:51Application of Electrophysiology Measurement to Study the Activity of Electro-Neutral Transporters
Published on: February 3, 2018
7.0K
相关概念视频
IP3/DAG Signaling Pathway
12.1K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.1K
Phosphoinositides and PIPs
8.6K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.6K
What are Second Messengers?
83.8K
Because many receptor binding ligands are hydrophilic, they do not cross the cell membrane and thus their message must be relayed to a second messenger on the inside. There are several second messenger pathways, each with their own way of relaying information. G-protein coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol path is active when the receptor induces phospholipase C to hydrolyze the phospholipid,...
83.8K
Insulin: The Receptor and Signaling Pathways
1.2K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.2K
Amplifying Signals via Second Messengers
7.0K
Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
7.0K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
